Patents Represented by Attorney Bradford Price
  • Patent number: 6613566
    Abstract: Platelet suspensions and methods for resuspending platelet concentrates are disclosed. The platelet concentrates are resuspended by combining a platelet concentrate with a substance capable of resuspending platelets, such as a salt solution. The resuspended platelets may be stored and/or administered to a patient.
    Type: Grant
    Filed: October 26, 2001
    Date of Patent: September 2, 2003
    Assignee: Baxter International Inc.
    Inventors: Richard L. Kandler, Liam C. Farrell
  • Patent number: 6080322
    Abstract: Blood separation systems and methods utilize a membrane separation device comprising a gap between a microporous membrane and a surface facing the microporous membrane, one of the microporous membrane and the surface being rotatable relative to the other to cause separation of whole blood in the gap into plasma and concentrated red blood cells. The systems and methods include an inlet pump element coupled to the membrane separation device to convey whole blood having a known beginning hematocrit value into the gap for separation. The systems and methods also include a drive element coupled to the membrane separation device to cause rotation of the rotatable one of the microporous membrane and the facing surface. The systems and methods command the inlet pump element and the drive element as a function of the known beginning hematocrit value.
    Type: Grant
    Filed: May 5, 1998
    Date of Patent: June 27, 2000
    Assignee: Baxter International Inc.
    Inventors: Jose C. Deniega, Daniel H. Duff
  • Patent number: 4840017
    Abstract: A flexible collapsible container is filled with fluid by connecting a fluid conduit to a tubular port which communicates through one of the walls of the container to the container interior, and rupturing a sealing diaphragm that closes the bore of the tubular port. One then passes fluid through the conduit to fill the container. Thereafter, one seals either or both the tubular port and plastic wall which carries it to the other, opposed plastic wall of the container with seal line means to close off flow communication between the bore of the tubular port and a major portion of the container interior which contains the fluid. The effect of this is to block flow communication between the bore and the fluid so that the contents of the container remain sealed on disengagement of the fluid conduit from the tubular port.
    Type: Grant
    Filed: August 3, 1987
    Date of Patent: June 20, 1989
    Assignee: Baxter Healthcare Corporation
    Inventors: Robert A. Miller, Albert L. Stone
  • Patent number: 4467588
    Abstract: Provided is a process for preparing an aseptic container for separately storing a sterilized powdered component and a sterilized liquid component under clean conditions. The container includes two sealed chambers having a frangible, sterilized connection therebetween, one said chamber containing the liquid component, and the other said chamber including a sealed vial containing a powdered component. The vial has an outer surface that is aseptic throughout its entire surface area, and the frangible connection provides a sterile pathway, when desired, between the interior of the vial and the interior of the liquid-containing chamber.
    Type: Grant
    Filed: April 6, 1982
    Date of Patent: August 28, 1984
    Assignee: Baxter Travenol Laboratories, Inc.
    Inventor: Peter Carveth